Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAART for AIDS-related Kaposi's Sarcoma in Zimbabwe
NCT00834457Phase 3Completed
- Sponsor
- Parirenyatwa Group of Hospitals
- Start
- Jun 2007
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lopinavir + ritonavir, sponsored by Parirenyatwa Group of Hospitals. Started Jun 2007; status: completed.
02
Drugs
lopinavir + ritonavir
Beyond the preview
Go deeper on NCT00834457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00834457.